Hudson Krystalyn E, de Wolski Karen, Kapp Linda M, Richards Amanda L, Schniederjan Matthew J, Zimring James C
Bloodworks Northwest Research Institute, Seattle, WA, United States.
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States.
Front Immunol. 2017 Oct 30;8:1425. doi: 10.3389/fimmu.2017.01425. eCollection 2017.
Red blood cells (RBCs) have a well-defined lifespan, indicating a mechanism by which senescent cells of a certain age are removed from circulation. However, the specifics by which senescent cells are recognized and removed are poorly understood. There are multiple competing hypotheses for this process, perhaps the most commonly cited is that senescent RBCs expose neoantigens [or senescent antigen(s)] that are then recognized by naturally occurring antibodies, which opsonize the senescent cells and result in clearance from circulation. While there are a large volume of published data to indicate that older RBCs accumulate increased levels of antibody on their surface, to the best of our knowledge, the causal role of such antibodies in clearance has not been rigorously assessed. In the current report, we demonstrate that RBC lifespan and clearance patterns are not altered in mice deficient in antibodies, in C3 protein, or missing both. These data demonstrate that neither antibody nor C3 is required for clearance of senescent RBCs, and questions if they are even involved, in a murine model of RBC lifespan.
红细胞(RBCs)具有明确的寿命,这表明存在一种机制可将特定年龄的衰老细胞从循环中清除。然而,衰老细胞被识别和清除的具体细节尚不清楚。关于这个过程有多种相互竞争的假说,也许最常被引用的假说是衰老的红细胞会暴露新抗原[或衰老抗原],然后这些新抗原会被天然存在的抗体识别,这些抗体使衰老细胞被调理,从而导致其从循环中清除。虽然有大量已发表的数据表明,衰老的红细胞表面会积累越来越多的抗体,但据我们所知,此类抗体在清除过程中的因果作用尚未得到严格评估。在本报告中,我们证明在缺乏抗体、C3蛋白或两者都缺失的小鼠中,红细胞寿命和清除模式并未改变。这些数据表明,在红细胞寿命的小鼠模型中,清除衰老红细胞既不需要抗体也不需要C3,并对它们是否参与其中提出了疑问。